Advertisements

Pivotal Therapeutics Inc. (PVO:CNX) Stock Quote

Detailed Quote for Pivotal Therapeutics Inc. (PVO:CNX)
$ 0.09 0.00 (0.00%) Volume: 19k 12:50 PM EDT Apr 20, 2015
Today 5d 1m 3m 1y more
Last Price
0.09
Change $
Change %
Tick
  
Bid
0.08
Bid Size
10,000
Ask
0.10
Ask Size
38,000
Open
0.095
High
0.10
Low
0.09
Prev Close
0.09
Last Trade
04/20/15
Volume
19k
52 Wk Hi
0.19
52 Wk Low
0.02
Market Cap
8.48m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
94,232,988
EPS (TTM)
-0.07
PE Ratio
N/A
Exchange
CSE
News and Media for Pivotal Therapeutics Inc. (PVO:CNX)
Sector News | Topic News
News for Pivotal Therapeutics Inc. (PVO:CNX)
Wed, Apr 15, 2015
9:10 AM Pivotal executes Memorandum of Understanding for exclusive distribution of Benefishial(TM) line of products in Korea - Canada Newswire
9:10 AM Pivotal executes Memorandum of Understanding for exclusive distribution of Benefishial(TM) line of products in Korea - PR Newswire
Tue, Apr 07, 2015
11:00 AM Pivotal Therapeutics and French University Hospital of Strasbourg Announce POMEGA Trial Chief Investigator Dr. Yannick Georg Laureate of EUR 30,000 French Interregional Clinical Research and Innovation Award For Investigating the Therapeutic Value of Its Novel VASCAZEN\u00AE Formulation in France - PR Newswire
11:00 AM Pivotal Therapeutics and French University Hospital of Strasbourg Announce POMEGA Trial Chief Investigator Dr. Yannick Georg Laureate of EUR 30,000 French Interregional Clinical Research and Innovation Award For Investigating the Therapeutic Value of Its Novel VASCAZEN\u00AE Formulation in France - Canada Newswire
Wed, Apr 01, 2015
4:16 PM Pivotal Receives Notice of Allowance For U.S. Patent Related to a Kit for the Dietary Management of Cardiovascular Patients That Includes VASCAZEN\u00AE and an Omega-3 Fatty Acid Diagnostic Assay - PR Newswire
3:44 PM Pivotal Receives Notice of Allowance For U.S. Patent Related to a Kit for the Dietary Management of Cardiovascular Patients That Includes VASCAZEN\u00AE and an Omega-3 Fatty Acid Diagnostic Assay - Canada Newswire
3:44 PM Pivotal Receives Notice of Allowance For U.S. Patent Related to a Kit for the Dietary Management of Cardiovascular Patients That Includes VASCAZEN\u00AE and an Omega-3 Fatty Acid Diagnostic Assay - PR Newswire
Thu, Mar 26, 2015
5:13 PM Pivotal Therapeutics announces payment of interest on outstanding convertible notes - Canada Newswire
5:13 PM Pivotal Therapeutics announces payment of interest on outstanding convertible notes - PR Newswire
Tue, Feb 10, 2015
12:41 PM IIROC Trade Resumption - PVO - Canada Newswire
12:28 PM Pivotal announces the issuance of two patents both related to the combination of VASCAZEN\u00AE with key Cholesterol Lowering Agents (Statins) and Cholesterol Absorption Inhibitors - Canada Newswire
12:28 PM Pivotal announces the issuance of two patents both related to the combination of VASCAZEN\u00AE with key Cholesterol Lowering Agents (Statins) and Cholesterol Absorption Inhibitors - PR Newswire
12:24 PM IIROC Trading Halt - PVO - Canada Newswire
Tue, Jan 27, 2015
1:23 PM Pivotal Therapeutics Receives Final Approval for Phase IIa Clinical Trial With PVT-100 - Canada Newswire
1:23 PM Pivotal Therapeutics Receives Final Approval for Phase IIa Clinical Trial With PVT-100 - PR Newswire
Thu, Jan 22, 2015
3:38 PM Pivotal Therapeutics: Year in Review and CEO Update - Canada Newswire
3:38 PM Pivotal Therapeutics: Year in Review and CEO Update - PR Newswire
Mon, Jan 05, 2015
5:10 PM Pivotal Therapeutics announces payment of interest on outstanding convertible notes - Canada Newswire
5:10 PM Pivotal Therapeutics announces payment of interest on outstanding convertible notes - PR Newswire
Wed, Dec 17, 2014
7:32 AM VASCAZEN\u00AE POMEGA Phase IIa Trial Protocol Cleared Clinical Evaluation by French FDA - PR Newswire
More News for PVO:CNX >>

Tags for Pivotal Therapeutics Inc.

Research stocks or mutual funds related to Pivotal Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to PVO:CNX. The keywords below have been associated to PVO:CNX by either user submission or electronic means.